Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes

Biochemical and Biophysical Research Communications

Volumn 410, Issue 1, 2011, Pages 1-6

  Kimura, Rino ^a   Takahashi, Nobuyuki ^a   Murota, Kaeko ^b   Yamada, Yuko ^a   Niiya, Saori ^a   Kanzaki, Noriyuki ^a   Murakami, Yoko ^a   Moriyama, Tatsuya ^b   Goto, Tsuyoshi ^a   Kawada, Teruo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Bezafibrate; Caco 2; Fatty acid oxidation; Intestine; PPAR

Indexed keywords

ACYL COENZYME A OXIDASE; APOLIPOPROTEIN B; BEZAFIBRATE; CARBON DIOXIDE; CARNITINE PALMITOYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; MESSENGER RNA; OLIVE OIL; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL METABOLIC RATE; CARBON DIOXIDE BLOOD LEVEL; CELL STRAIN CACO 2; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID OXIDATION; HYPERLIPIDEMIA; IN VIVO STUDY; INTESTINE CELL; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ANIMALS; BEZAFIBRATE; CACO-2 CELLS; ENTEROCYTES; FATTY ACIDS; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; POSTPRANDIAL PERIOD; PPAR ALPHA; TRIGLYCERIDES;

MUS;

EID: 79959373746     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.057     Document Type: Article

References (22)

1. Lefebvre P., Chinetti G., Fruchart J.C., Staels B. Sorting out the roles of PPAR-alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 2006, 116:571-580.
2. Takahashi N., Goto T., Hirai S., Uemura T., Kawada T. Genome science of lipid metabolism and obesity. Forum Nutri. 2009, 61:25-38.
3. Mandard S., Müllar M., Kersten S. Peroxisome proliferator-activated receptors-alpha target genes. Cell. Mol. Life Sci. 2004, 61:393-416.
4. Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 1996, 37:907-925.
5. Takahashi N., Kawada T., Goto T., Yamamoto T., Taimatsu A., Matsui N., Kimura K., Saito M., Hosokawa M., Miyashita K., Fushiki T. Dual action of isoprenols from herbal medicines on both PPAR-gamma and PPAR-alpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 2002, 514:315-322.
6. Goto T., Takahashi N., Kato S., Egawa K., Ebisu S., Moriyama T., Fushiki T., Kawada T. Phytol directly activates PPAR-alpha and regulates gene expression involved in lipid metabolism in PPAR-alpha-expressing HepG2 hepatocytes. Biochem. Biophys. Res. Commun. 2005, 337:440-445.
7. Takahashi N., Kang K.M., Kuroyanagi K., Goto T., Hirai S., Ohyama K., Lee J.Y., Yu R., Yano M., Sasaki T., Murakami S., Kawada T. Auraptene, a citrus fruit compound, regulates gene expression as a PPAR-alpha agonist in HepG2 hepatocytes. BioFactors 2008, 33:25-32.
8. Kang M.S., Hirai S., Goto T., Kuroyanagi K., Kim I.Y., Ohyama K., Uemura T., Lee J.Y., Sakamoto T., Ezaki Y., Yu R., Takahashi N., Kawada T. Dehydroabietic acid a phytochemical acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation of mouse adipose tissues. BioFactors 2009, 35:442-448.
9. Goto T., Lee J.Y., Teraminami A., Kim Y.I., Hirai S., Uemura T., Inoue H., Takahashi N., Kawada T. Activation of PPAR-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J. Lipid Res. 2011, 52:873-884.
10. Yamashita S., Hirano K., Kuwasako T., Janabi M., Toyama Y., Ishigami M., Sakai N. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol. Cell. Biochem. 2007, 299:19-22.
11. Patsch J.R., Miesenbock G., Hopferwieser T., Muhlberger V., Knapp E., Dunn J.K., Gotto A.M., Patsch W. Relation of triglyceride metabolism and coronary artery disease. Arterioscl. Thronb. 1992, 12:1336-1345.
12. Hsieh J., Longuet C., Maida A., Bahrami J., Xu E., Baker C.L., Brubaker P.L., Drucker D.J., Adeli K. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 2009, 137:997-1005.
13. Drover V.A., Ajmal M., Nassir F., Davidson N.O., Nauli A.M., Sahoo D., Tso P., Abumrad N.A. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest. 2005, 115:1290-1297.
14. Takahashi N., Kawada T., Yamamoto T., Goto T., Taimatsu A., Aoki N., Kawasaki H., Taira K., Yokoyama K.K., Kamei Y., Fushiki T. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CBP and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of PPAR-gamma. J. Biol. Chem. 2002, 277:16906-16912.
15. Uemura T., Goto T., Kang M.S., Mizoguchi N., Hirai S., Lee J.Y., Nakano Y., Shono J., Hoshino S., Taketani K., Tsuge N., Narukami T., Makishima M., Takahashi N., Kawada T. Diosgenin the main aglycon of fenugreek inhibits LXR-alpha activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J. Nutr. 2011, 141:17-23.
16. Mochizuki Y., Maebuchi M., Kohno M., Hirotsuka M., Wadahama H., Moriyama T., Kawada T., Urade R. Changes in lipid metabolism by soy beta-conglycinin-derived peptides in HepG2 cells. J. Agric. Food. Chem. 2009, 57:1473-1480.
17. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., Messaddeq N., Harney J.W., Ezaki O., Kodama T., Schoonjans K., Bianco A.C., Auwerx J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
18. Ballinger A., Peikin S.R. Orlistat: its current status as an anti-obesity drug. Eur. J. Pharmacol. 2002, 440:109-117.
19. Lucas K.H., Kaplan-Machlis B. Orlistat: a novel weight loss therapy. Ann. Pharmacother. 2001, 35:314-328.
20. Hauptman J., Lucas C., Boldrin M.N., Collins H., Segal K.R. Orlistat in the long-term treatment of obesity in primary care settings. Arch. Fam. Med. 2000, 9:160-167.
21. Kuroyanagi K., Kang M.S., Goto T., Hirai S., Ohyama K., Kusudo T., Yu R., Yano M., Sasaki T., Takahashi N., Kawada T. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2008, 366:219-225.
22. T. Goto, N. Takahashi, S. Hirai, T. Kawada, Various terpenoids derived from herbal and dietary plants function as PPAR modulators and regulate carbohydrate and lipid metabolism, PPAR Res. (2010) Article ID 483958.